Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Promised Land for Biotechnology

This article was originally published in Start Up

Executive Summary

Israel is the hottest single country for high-tech start-ups in general, but advocates of life sciences say that additional funding specifically for biotechnology is needed. Without a strong pharmaceutical industry, Israel lacks the infrastructure necessary to nurture start-ups, for example, experienced executives to run companies.

You may also be interested in...



CellStain Technologies Ltd.

CellStain Technologies believes it has created a staining technique that emphasizes only malignant cells in a diagnostic sample, promising to take some of the subjectivity out of cancer screening.

Sol-Gel Technologies Ltd.

Sol-Gel Technologies' manufacturing process for the encapsulation of bioactive molecules in a bioactive glass under gentle manufacturing conditions has many applications in health care.

Proneuron Biotechnologies

Proneuron will develop new cell therapies and treatments for neurological disorders such as multiple sclerosis, Parkinson's diseases and Alzheimer's disease, ophthalmological disorders including anterior ischemic optic neuropathy and glaucoma, and immune disorders.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel